Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation

Preliminary

1. Appropriate contact details for further information?

Yes

2. Authors identified?

Yes

3. Statement regarding conflict of interest?

Yes

4. Statement on whether report externally reviewed?

Yes

5. Short summary in non-technical language?

Yes

Why?

6. Reference to the policy question that is addressed?

Yes

7. Reference to the research question that is addressed?

Yes

8. Scope of the assessment specified?

Yes

9. Description of the assessed health technology?

Yes

How?

10. Details on sources of information and literature search strategies provided?

Search strategy
Databases
Year range
Language restriction
Primary data
Other kind of information resources
Complete reference list of included studies
List of excluded studies
Inclusion criteria
Exclusion criteria

11. Information on basis for the assessment and interpretation of selected data and information?

Method of data extraction described?
Critical appraisal method (for quality assessment of the literature) described?
Method of data synthesis described?
Results of the assessment clearly presented, e.g. in the form of evidence tables?

Context?

12. Information on context (may or may not apply to each HTA).

Economic analysis provided?
Ethical implications considered?
Social implications considered?
Other perspectives (stakeholders, patients, consumers) considered?